Gelesis Holdings Inc. (GLS) Fundamentals

Gelesis Holdings Inc is a biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Its portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH), and Functional Constipation.
SHARE INFORMATION
Market Cap$ 35,056,082
Shares Outstanding73,033,504
Float20,066,587
Percent Float27.48%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 11,185,000
Latest Fiscal EPS$ -2.60
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions91
Institutional Holdings Date2022-11-30
Institutional Bought Previous 3 Months3,657,936
Institutional Holdings Percent28.0%
Institutional Sold Previous 3 Months2,674,817
Insider Holdings Date2022-11-30
Insider Bought Previous 3 Months100,000
Insider Holdings Percent6.5
Insider Sold Previous 3 Months-
Insider Shares Owned4,737,811
TRADING INFO
52 Week High$ 12.23
52 Week Low$ 0.24
52 Week High Change$ -95.18
21 Day Moving Average$ 0.3618
21 Day Extended Moving Average$ 0.418526
50 Day Moving Average$ 0.6246
50 Day Extended Moving Average$ 0.622964
200 Day Moving Average$ 2.4209
200 Day Extended Moving Average$ 2.6078
10 Day Average Volume139,661
20 Day Average Volume173,146
30 Day Average Volume161,991
50 Day Average Volume122,042
Alpha-0.081997
Beta0.8696
Standard Deviation0.221494
R20.046256
7 Day Price Change$ 0.0962
7 Day Percent Change25.07%
21 Day Price Change$ 0.135
21 Day Percent Change39.13%
30 Day Price Change$ 0.17
30 Day Percent Change54.84%
Month to Date Price Change$ 0.11
Month to Date Percent Change29.73%
Quarter to Date Price Change$ -0.60
Quarter to Date Percent Change-55.56%
180 Day Price Change$ -4.47
180 Day Percent Change-90.3%
200 Day Price Change$ -4.52
200 Day Percent Change-90.4%
Year to Date Price Change$ -9.48
Year to Date Percent Change-95.18%

Gelesis Holdings Inc. (GLS) Key Ratios

PROFITABILITY
EBIT Margin-421.7%
EBITDA Margin-370.7%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin39.6%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 26,031,000
Revenue Per Share$ 0.3564
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-9.80
Total Debt To Equity6.90
Int Coverage-56.40
Current Ratio1.10
Leverage Ratio49.30
Quick Ratio0.70
Long Term Debt To Capital0.86
VALUATION MEASURES
PE Ratio-0.70
Enterprise Value$ 68,699,081
Price to Sales1.3467
Price to Free Cash-0.30
PE High Last 5 Years0.00
Price To Book5.20
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book-9.80
MANAGEMENT EFFECTIVENESS
Receivables Turnover5.50
Invoice Turnover1.40
Assets Turnover0.40
Return Assets-34.35
Return on Equity1,247.07
Return on Capital-148.81

Gelesis Holdings Inc. (GLS) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
Auditor-
CEOYishai Zohar
Emplyoees101
Last Audit-
CIK0001805087
IndustryBiotechnology
SectorHealthcare
NAICSResearch and Development in Biotechnology (except Nanobiotechnology)(541714)
CONTACT INFO
Address405 West 14th Street
Austin, TX 78701
Websitehttps://www.gelesis.com
Facsimile-
Telephone+1 512 340-7800
Email-


Your Recent History
NYSE
GLS
Gelesis
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.